Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Gen Surg SAQssurgical-critical-care

Gen Surg SAQs · surgical-critical-care

Bleeding after damage-control laparotomy — activate, ratio, TXA, fibrinogen and calcium

Fellowship SAQ on surgical massive transfusion: MTP triggers and scores, PROPPR ratios with plasma-first sequencing, CRASH-2 TXA timing, CRYOSTAT-2 fibrinogen restraint, calcium replacement and whole-blood selection.

10 marks12 min2 min readVerification in progress

Target exams

FRACSFRCS(Gen Surg)ABSFRCSC
On this page
Study tools

Target exams

FRACSFRCS(Gen Surg)ABSFRCSC
Prompt
A 41-year-old man is 90 minutes after damage-control laparotomy with packing for a grade IV liver injury and pelvic binder for an unstable pelvic fracture. He remains hypotensive (systolic pressure 82, heart rate 126) with ongoing drain output, 3 units of red cells already transfused, ionised calcium 0.94 mmol/L, fibrinogen reported low on the first round, injury 2 hours ago. (A) Justify MTP activation now with scores and triggers, and state the ratio, sequence and speed of resuscitation. (4 marks) (B) Give the TXA decision with dosing and timing numbers, and the fibrinogen decision with trial numbers. (3 marks) (C) Manage his calcium with numbers, state the whole-blood versus component choice, and name the VTE watch. (3 marks)

Write your answer

Saved on this device. No marking — you are the marker.

Model answer

(A) Activate now on physiology — balanced 1:1:1 fast with plasma early (4 marks). Hypotension with ongoing drain output after 3 units meets clinical MTP triggers — and among trigger-meeting patients, even 1 to 3 units carry no excess harm signal, so activation cannot be called over-triage in retrospect.[9] Score it formally: TASH is the most well validated trigger score, ABC balances accuracy with ease where laboratories lag, and shock index runs on vitals alone with fair performance — use all three layers, and transfuse while tallying.[6] Resuscitate 1:1:1 plasma-platelets-red cells during active bleeding per PROPPR (338 vs 342 patients; exsanguination 9.2% vs 14.6%, haemostasis 86% vs 78%, with 23 complications equal) — within the accepted 1:1:1 to 1:1:2 protocol range — sequencing plasma early (red-cell-first carries worse adjusted 6-hour, 24-hour and in-hospital mortality) and delivering fast, because shorter time to blood means better outcomes.[1][25][8]

(B) TXA now — 1 g load inside the 2-hour window; fibrinogen only if the level with bleeding justifies it (3 marks). Injury was 2 hours ago, so give TXA 1 g loading over 10 minutes then 1 g over 8 hours immediately: CRASH-2 dosing cut all-cause death (14.5% vs 16.0%) and bleeding death (4.9% vs 5.7%).[2] Timing is the whole decision — within 1 hour RR 0.68, 1 to 3 hours RR 0.79, after 3 hours harm RR 1.44 — and the pooled optimal criterion is treatment within 2 hours of injury, which he still meets.[3][4] For low fibrinogen with active bleeding, replace by local protocol for documented hypofibrinogenaemia — but do not protocolise empirical cryoprecipitate for every activation (no verified threshold is quoted here; use your protocol's number): CRYOSTAT-2 (3 pools, 6-g equivalent, within 90 minutes) gave 28-day death 25.3% vs 26.1% with equal thrombosis, and the 5-trial meta-analysis found 24% vs 25% (OR 1.03).[10][11]

(C) Calcium 0.94 is low — replace under load and recheck; whole blood suits his pressure; watch for early PE (3 marks). Ionised 0.94 meets the verified hypocalcaemia threshold (1.0 or less): plasma transfusion raised hypocalcaemia to 53% vs 36% with severe lows tied to decreased survival — yet arrival means sit at 1.08 regardless of transfusion, so his level reflects shock plus citrate and earns replacement with rechecks each round, consistent with the whole-blood dosing signal (1 g or more calcium chloride per 2 units, OR 0.164 for 24-hour death).[14][16][15] At systolic pressure 82 he sits in the whole-blood-benefit subgroup (below-90 aOR 0.72) — offer low-titre O whole blood first where available, otherwise reconstituted 1:1:1, stating the observational limit aloud.[19] From haemostasis, start mechanical VTE prophylaxis and convert to pharmacologic cover promptly: 13% of PROPPR patients developed VTE with pulmonary embolus predominant in the first 72 hours.[21]

References15ShowHide
  1. [1]Holcomb JB, Tilley BC, Baraniuk S, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA, 2015.PMID 25647203
  2. [2]Shakur H, Roberts I, Bautista R, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet, 2010.PMID 20554319
  3. [3]Roberts I, Shakur H, Afolabi A, et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet, 2011.PMID 21439633
  4. [4]Osawa I, Goto T, Roberts I, et al. Tranexamic acid for trauma: optimal timing of administration based on the CRASH-2 and CRASH-3 trials. Br J Surg, 2025.PMID 40277024
  5. [6]Shih AW, Al Khan S, Wang AY, et al. Systematic reviews of scores and predictors to trigger activation of massive transfusion protocols. J Trauma Acute Care Surg, 2019.PMID 31454339
  6. [8]Meneses E, Boneva D, McKenney M, et al. Massive transfusion protocol in adult trauma population. Am J Emerg Med, 2020.PMID 33071074
  7. [9]Gelbard RB, Griffin RL, Reynolds L, et al. Over-transfusion with blood for suspected hemorrhagic shock is not associated with worse clinical outcomes. Transfusion, 2022.PMID 35753037
  8. [10]Davenport R, Curry N, Fox EE, et al. Early and Empirical High-Dose Cryoprecipitate for Hemorrhage After Traumatic Injury: The CRYOSTAT-2 Randomized Clinical Trial. JAMA, 2023.PMID 37824155
  9. [11]Burt T, Guilliam A, Cole E, et al. Effect of early administration of fibrinogen replacement therapy in traumatic haemorrhage: a systematic review and meta-analysis of randomised controlled trials with narrative synthesis of observational studies. Crit Care, 2025.PMID 39875966
  10. [14]Moore HB, Tessmer MT, Moore EE, et al. Forgot calcium? Admission ionized-calcium in two civilian randomized controlled trials of prehospital plasma for traumatic hemorrhagic shock. J Trauma Acute Care Surg, 2020.PMID 32317575
  11. [15]Rajesh A, Barry L, Limon D, et al. Aggressive calcium chloride dosing reduces early mortality in trauma patients receiving whole blood resuscitation. J Trauma Acute Care Surg, 2026.PMID 41995161
  12. [16]Rushton TJ, Tian DH, Baron A, et al. Hypocalcaemia upon arrival (HUA) in trauma patients who did and did not receive prehospital blood products: a systematic review and meta-analysis. Eur J Trauma Emerg Surg, 2024.PMID 38319350
  13. [19]Torres CM, Stolarski AE, Kenzik KM, et al. Identifying trauma patients who benefit from whole blood transfusion: An effect decomposition analysis on patient survival. Transfusion, 2025.PMID 40717387
  14. [21]Myers SP, Brown JB, Leeper CM, et al. Early versus late venous thromboembolism: A secondary analysis of data from the PROPPR trial. Surgery, 2019.PMID 31230842
  15. [25]Hynes AM, Westein RJ, Turner TJ, et al. Fresh frozen plasma-first approach is independently associated with improved survival in severely injured patients undergoing massive transfusion. J Trauma Acute Care Surg, 2026.PMID 42275580
PreviousARDS on day 2 after laparotomy — define by Berlin, set the ventilator, prone and drysurgical-critical-careNextBleeding laparotomy with consumption — SIC screen, JAAM-2 start, transfuse and time TXAsurgical-critical-care